Exchange traded funds (ETFs) tracking pharmaceutical and healthcare stocks could see action Monday on news Johnson & Johnson (NYSE: JNJ) is on the prowl for acquisitions and earnings from Eli Lilly (NYSE: LLY).

Swiss device maker Synthes confirmed it is in merger negotiations with J&J, according to reports. Shares of U.K. medical technology company Smith & Nephew traded lower as takeover hopes suffered a blow after the bid for Synthes, MarketWatch reported.

Separately, Eli Lilly said its first-quarter profit fell from the year-earlier period.

The largest healthcare ETFs by assets include Health Care SPDR (NYSEArca: XLV), Vanguard Health Care ETF (NYSEArca: VHT) and iShares Dow Jones U.S. Healthcare (NYSEArca: IYH).

In pharma ETFs, the most popular offerings include Pharmaceuticals HOLDRS (AMEX: PPH), SPDR S&P Pharmaceuticals ETF (NYSEArca: XPH) and iShares Dow Jones U.S. Pharmaceuticals (NYSEArca: IHE).

Health Care SPDR

Post Comment

Do NOT follow this link or you will be banned from the site!